KEYTRUDA (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Advanced Malignant Pleural...
RAHWAY, N.J. & KINGSTON, Ontario--(BUSINESS WIRE)--Mar 10, 2023--
RAHWAY, N.J. & KINGSTON, Ontario--(BUSINESS WIRE)--Mar 10, 2023--